TrialPediatric rheumatology online journal2021

Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial.

Saori Fukui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.